日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

在接受过大量预处理的复发或难治性多发性骨髓瘤患者中,使用ciltacabtagene autoleucel治疗后出现细胞减少症和感染

Dima, Danai; Logue, Jennifer M; Waqar, Syed Hamza Bin; Peres, Lauren C; Colin-Leitzinger, Christelle M; De Avila, Gabriel; Smith, Eric C; Skelson, Lawrence; Matte, Kristy L; Blue, Brandon; Hovanky, Vanna N; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B; Fortuna, Gliceida Galarza M; Wagner, Charlotte B; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L; Shain, Kenneth H; Baz, Rachid C; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L; Shune, Leyla O; Sborov, Douglas W; Patel, Krina K; Sidana, Surbhi; Hansen, Doris K

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

复发/难治性多发性骨髓瘤标准治疗方案 Idecabtagene Vicleucel 与 Ciltacabtagene Autoleucel 的比较

Hansen, Doris K; Peres, Lauren C; Dima, Danai; Richards, Alicia; Shune, Leyla; Afrough, Aimaz; Midha, Shonali; Dhakal, Binod; Kocoglu, Mehmet H; Atrash, Shebli; Ferreri, Christopher; Castaneda, Omar; Davis, James A; Bhurtel, Evguenia; McGuirk, Joseph; Wagner, Charlotte; Bansal, Radhika; Costello, Patrick; Smith, Kinaya; Lieberman-Cribbin, Alex; De Avila, Gabriel; Purvey, Sneha; Hosoya, Hitomi; Mikkilineni, Lekha; Oswald, Laura B; Kaur, Gurbakhash; Pasvolsky, Oren; Gaballa, Mahmoud; Herr, Megan M; Forsberg, Peter; Janakiram, Murali; Htut, Myo; Asoori Maringanti, Sireesha; Kalariya, Nilesh; Hashmi, Hamza; Reshef, Ran; Sborov, Douglas W; Nadeem, Omar; Anwer, Faiz; Khouri, Jack; Raza, Shahzad; Atanackovic, Djordje; Alsina, Melissa; Freeman, Ciara L; Locke, Frederick L; Voorhees, Peter; Anderson, Larry D Jr; Richard, Shambavi; Martin, Thomas; Lin, Yi; Patel, Krina K; Sidana, Surbhi

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

标准疗法 ciltacabtagene autoleucel 治疗复发/难治性多发性骨髓瘤的安全性和有效性

Sidana, Surbhi; Patel, Krina K; Peres, Lauren C; Bansal, Radhika; Kocoglu, Mehmet H; Shune, Leyla; Atrash, Shebli; Smith, Kinaya; Midha, Shonali; Ferreri, Christopher; Dhakal, Binod; Dima, Danai; Costello, Patrick; Wagner, Charlotte; Reshef, Ran; Hosoya, Hitomi; Mikkilineni, Lekha; Atanackovic, Djordje; Chhabra, Saurabh; Parrondo, Ricardo; Nadeem, Omar; Mann, Hashim; Kalariya, Nilesh; Hovanky, Vanna; De Avila, Gabriel; Freeman, Ciara L; Locke, Frederick L; Alsina, Melissa; Wong, Sandy; Herr, Megan; Htut, Myo; McGuirk, Joseph; Sborov, Douglas W; Khouri, Jack; Martin, Thomas; Janakiram, Murali; Lin, Yi; Hansen, Doris K

Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma.

在多发性骨髓瘤中,来自早期未分选干细胞产品的 CAR-T 细胞功能和线粒体适应性得到增强

Freeman Ciara L, Abraham-Miranda Julieta, Menges Meghan, Atkins Reginald M, Noble Jerald, Liu Hien, Corallo Salvatore, Cuadrado Delgado Luis A, Ribickas Albert J, Savid-Frontera Constanza, de Avila Gabriel, Castaneda Puglianini Omar A, Ochoa-Bayona Jose, Hansen Doris K, Alsina Melissa, Baz Rachid, Nishihori Taiga, Shain Kenneth H, Locke Frederick L

Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

teclistamab治疗既往接受过BCMA靶向治疗的复发/难治性多发性骨髓瘤患者的疗效:一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

Dima, Danai; Vazquez-Martinez, Mariola A; Davis, James A; Goel, Utkarsh; Afrough, Aimaz; Sannareddy, Aishwarya; Pasvolsky, Oren; Razzo, Beatrice; Banerjee, Rahul; Khouri, Jack; Grajales-Cruz, Ariel; Lieberman-Cribbin, Alex; Rana, Masooma Shifa; Julian, Kelley; DeJarnette, Shaun; Portuguese, Andrew J; Gaballa, Mahmoud R; De Avila, Gabriel; Susaniba Adaniya, Sandra; Raza, Shahzad; Herr, Megan M; Ouchveridze, Evguenia; Richards, Tiffany; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; Castaneda Puglianini, Omar; Rossi, Adriana; Lin, Yi; Atrash, Shebli; Sborov, Douglas; Shain, Kenneth H; Voorhees, Peter M; Richard, Shambavi; Garfall, Alfred L; Hansen, Doris K; Sidana, Surbhi; Patel, Krina K; Cowan, Andrew J; Anderson, Larry D Jr; Lee, Hans C; Anwer, Faiz; Ferreri, Christopher J; Shune, Leyla

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience

髓外和骨旁浆细胞瘤对接受teclistamab治疗的多发性骨髓瘤患者治疗结果的影响:美国骨髓瘤免疫治疗联盟的真实世界经验

Afrough, Aimaz; Dima, Danai; Razzo, Beatrice; Goel, Utkarsh; Sannareddy, Aishwarya; Pasvolsky, Oren; Vazquez-Martinez, Mariola A; Ferreri, Christopher J; Banerjee, Rahul; Khouri, Jack; Davis, James A; Gaballa, Mahmoud R; Lieberman-Cribbin, Alex; Rana, Masooma S; Julian, Kelley; Anwer, Faiz; Shune, Leyla; DeJarnette, Shaun; Grajales-Cruz, Ariel F; Ouchveridze, Evguenia; De Avila, Gabriel; Susanibar-Adaniya, Sandra P; Portuguese, Andrew J; Schrum, Daniel; Eberwein, Erin; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; McGuirk, Joseph P; Rossi, Adriana; Herr, Megan M; Castaneda, Omar; Locke, Frederick L; Raza, Shahzad; Lin, Yi; Atrash, Shebli; Sborov, Douglas W; Voorhees, Peter M; Richard, Shambavi; Garfall, Alfred L; Sidana, Surbhi; Patel, Krina K; Hansen, Doris K; Cowan, Andrew J; Anderson, Larry D Jr; Lee, Hans C

Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma

复发/难治性多发性骨髓瘤患者接受抗BCMA CAR-T治疗后的心血管不良事件和预后

Palfi, Stefanie; Peres, Lauren C; Koelmeyer, Himara; Alsina, Melissa; Baz, Rachid C; Blue, Brandon J; Corallo, Salvatore; De Avila, Gabriel; Freeman, Ciara; Gonzalez, Rebecca; Grajales-Cruz, Ariel; Harvey, Kristy; Liu, Hien D; Nishihori, Taiga; Oliveira, Guilherme H; Oswald, Laura B; Castaneda Puglianini, Omar; Selvakumar, Sruthi; Sharma, Alexis Behne; Wang, Elicia; Shain, Kenneth H; Jain, Michael; Locke, Frederick L; Alomar, Mohammed; Hansen, Doris K; Lee, Dae Hyun

Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease

多发性骨髓瘤患者接受BCMA靶向CAR-T细胞治疗后的疾病进展结局:髓外和髓旁疾病的影响

Abuhelwa, Ziad; Amisha, Fnu; Fan, Wenyi; De Avila, Gabriel; Hansen, Doris K; Grajales-Cruz, Ariel F; Blue, Brandon; Castaneda, Omar; Liu, Hien; Freeman, Ciara L; Nishihori, Taiga; Locke, Frederick L; Shain, Kenneth H; Baz, Rachid; Alsina, Melissa

Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium real world experience

复发/难治性多发性骨髓瘤患者接受idecabtagene vicleucel治疗后出现耐药或早期进展的相关因素:美国骨髓瘤免疫治疗联盟的真实世界经验

Hashmi, Hamza; Hansen, Doris K; Peres, Lauren C; Puglianini, Omar Castaneda; Freeman, Ciara; De Avila, Gabriel; Sidana, Surbhi; Shune, Leyla; Sborov, Douglas W; Davis, James; Wagner, Charlotte; Kocoglu, Mehmet H; Atrash, Shebli; Voorhees, Peter; Simmons, Gary; Ferreri, Christopher; Kalariya, Nilesh; Anderson, Larry D Jr; Afrough, Aimaz; Dima, Danai; Khouri, Jack; McGuirk, Joseph; Locke, Fred; Baz, Rachid; Patel, Krina K; Alsina, Melissa

Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

CAR-T细胞疗法治疗多发性骨髓瘤患者的临床结果存在种族和民族差异

Peres, Lauren C; Oswald, Laura B; Dillard, Christen M; De Avila, Gabriel; Nishihori, Taiga; Blue, Brandon J; Freeman, Ciara L; Locke, Frederick L; Alsina, Melissa; Castaneda Puglianini, Omar; Shune, Leyla; Sborov, Douglas W; Wagner, Charlotte; Dima, Danai; Hashmi, Hamza; Davis, James A; Kocoglu, Mehmet H; Badros, Ashraf Z; Atrash, Shebli; Simmons, Gary; Kalariya, Nilesh; Ferreri, Christopher; Anderson, Larry D Jr; Afrough, Aimaz; Kaur, Gurbakhash; Lin, Yi; Liu, Lawrence; Nadeem, Omar; Voorhees, Peter; Khouri, Jack; McGuirk, Joseph; Sidana, Surbhi; Hansen, Doris K; Patel, Krina